Mars Bioimaging: Funding, Investors & Team (Oct 2026)
Mars Bioimaging Ltd (MBI) was formed in 2007 to commercialise the ground-breaking MARS imaging system for its applications in medical diagnosis. The MARS imaging system is based on the new generation Medipix chip licensed out of CERN, Switzerland and technology developed by the University of Canterbury (UC) and partners. It has established itself as the world’s leading spectral (multi-energy ‘true colour’) imaging technology. It is the first commercially available spectral, high definition computed tomography (CT) system and has already demonstrated exciting applications.
Mars Bioimaging has raised $15.0M across 1 funding round on record, the most recent a Series A of $15.0M announced in Jan 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Mars Bioimaging Company Profile and Key Stats
Latest funding round on record: Jan 2026.
Mars Bioimaging Funding Rounds
Mars Bioimaging Founders and Leadership Team
Contact details for the Mars Bioimaging team: 1 of 1 has an email address on file.
Start 14-day free trial →Mars Bioimaging Funding Compared to Other Biotechnology Startups
Mars Bioimaging's latest round of $15.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Mars Bioimaging in Biotechnology and Christchurch
Companies Similar to Mars Bioimaging
Pictor is an in-vitro diagnostics company that offers a patented multiplexed platform for highly accurate and…
Pacific Edge is a cancer diagnostics company. They specialise in discovering, building and commercialising…
Scentian Bio functions as a platform that offers a comprehensive sensing solution.
Algorae Pharmaceuticals is an Australasian biotechnology company working on AI-enhanced drug research and…
Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for…
Jooules provides a sustainable food solution that promotes a more environmentally friendly and healthier…
BioLinker is a creation of manufactured science, protein blend packs, and protein.
WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs…
Tydra Labs is a biotechnology company that transforms crustacean shell waste into chitin and bio-products.
M-Based develops new alternative material technologies using mushrooms. 🍄 We consider environmental…
Mars Bioimaging Funding FAQs
What does Mars Bioimaging do?
Mars Bioimaging Ltd (MBI) was formed in 2007 to commercialise the ground-breaking MARS imaging system for its applications in medical diagnosis. The MARS imaging system is based on the new generation Medipix chip licensed out of CERN, Switzerland and technology developed by the University of Canterbury (UC) and partners. It has established itself as the world’s leading spectral (multi-energy ‘true colour’) imaging technology. It is the first commercially available spectral, high definition computed tomography (CT) system and has already demonstrated exciting applications.
How much funding has Mars Bioimaging raised?
Mars Bioimaging has raised $15.0M across 1 round on record. The most recent is a Series A of $15.0M announced in Jan 2026.
When did Mars Bioimaging last raise funding?
Mars Bioimaging's most recent funding round on record is a Series A of $15.0M, announced in Jan 2026.
Who founded Mars Bioimaging?
FundedIQ lists Phil Butler (Founder) at Mars Bioimaging.
Where is Mars Bioimaging headquartered?
Mars Bioimaging is based in Christchurch, Canterbury, New Zealand.
How many employees does Mars Bioimaging have?
Mars Bioimaging is in the 11-50 employee band.
How does Mars Bioimaging's funding compare to other Biotechnology startups?
Mars Bioimaging's latest round of $15.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Mars Bioimaging Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Mars Bioimaging is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.